Institutional Repository of Vilnius University
ɑ-lipoinės rūgšties įtakos DNR reparacijos lygiui nustatymas diabetu sergančių asmenų limfocituose in vitro /
Abstract
dc:descriptionDiabetes mellitus is a group of disorders caused by defective carbohydrate metabolism. During diabetes, the number of free radicals in the organism increases, which leads to the development of various complications (neuropathy, nephropathy, and retinopathy). For this reason, antioxidants are used in the treatment of diabetes because, by maintaining redox homeostasis, they can contribute to the alleviation of symptoms and prevention of this disease. α-lipoic acid (ALA) is a universal antioxidant that can suppress oxidative stress damage. ALA and its reduced form, dihydrolipoic acid (DHLA), can act as free radical scavengers, metal chelators, and activators of other antioxidants by reducing or inhibiting inflammatory responses. These properties reveal the therapeutic potential of this redox couple. ALA mechanisms of action can improve DNA reparation mechanisms, which are damaged during oxidative stress, efficiency, aid in the reduction of DNA damage, and be used in disease treatment, such as diabetes. The aim of this research was to assess the effect of α-lipoic acid on DNA damage repair level in diabetic human peripheral blood lymphocytes (PBL) by the sister chromatid exchange (SCE) and cytokinesis-block micronucleus (CBMN) methods while using a 4-nitroquinoline-1-oxide (4NQO) mutagen sensitivity test. During the research, it was concluded that ALA did not contribute to the statistically significant reduction of the average SCE and micronucleus (MN) rates. It was also determined that the effect of ALA on SCE and MN rates was not significantly influenced by diabetic patient characteristics (age, body mass index, diabetes type, or associated complications). During the additional experiments, ALA, which was added to the control group subjects PBL cultures in vitro, reduced the SCE rate by a statistically significant amount only in the PBL treated with 0.02 µg/ml concentration of doxorubicin hydrochloride (DXR).
Degree
thesis:*- Grantor dc:publisher
- Institutional Repository of Vilnius University
- Year dc:date
- 2023
Author and committee
dc:creator, dc:contributor.*- Author dc:creator
-
- Žukaitė, Karolina,
Rights
dc:rights- Statement dc:rights
-
- info:eu-repo/semantics/openAccess
- Language dc:language
- lit
Identifiers
dc:identifier.*- Repository record dc:identifier
- https://repository.vu.lt/VU:ELABAETD192845299&prefLang=en_US